Radiother Oncol
Impact of internal target volume definition for pencil beam scanned proton treatment planning in the presence of respiratory motion variability for lung cancer: A proof of concept.
Krieger M, Giger A, Salomir R, Bieri O, Celicanin Z, Cattin PC, Lomax AJ, Weber DC, Zhang Y
Motion management is crucial in scanned proton therapy for mobile tumours. Current motion mitigation approaches rely on single 4DCTs before treatment, ...
Read More
Source: PubMed
Int. J. Radiat. Oncol. Biol. Phys. 2020 Jan 27
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM) at a Large Academic Cancer Center.
Waddle MR, Stross WC, Vallow LA, Naessens J, White L, Meier S, Spaulding A, Buskirk SJ, Trifiletti DM, Keole S, Ma D, Bajaj G, Laack NN, Miller RC
The proposed Radiation Oncology Alternative Payment Model (RO-APM) released on July 10, 2019 represents a dramatic shift from fee-for-service (FFS) re ...
Read More
Source: PubMed
Radiat Oncol
Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G, Li X, Qin A, Zheng W, Yan D, Zhang S, Stevens C, Kabolizadeh P, Ding X
To explore the dosimetric improvement, delivery efficiency, and plan robustness for bilateral head and neck cancer (HNC) treatment utilizing a novel p ...
Read More
Source: PubMed
Int J Part Ther
Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment.
Wieland J, Hoppe BS, Rausch-Osian SM, King JC, Sierra A, Hiemenz JW, Bradley J, Pham DC, Jones LM, Yeung AR, Hopper K, Mendenhall NP, Hitchcock KE
Treatment success in lung cancer is no longer restricted to objective measures of disease-specific outcomes and overall survival alone but now incorpo ...
Read More
Source: PubMed
Int J Part Ther
Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer.
Mendenhall WM, Smith S, Morris CG, Bradley JA, Mailhot Vega RB, McIntyre K, Klein SL, Mendenhall NP
To determine factors that influence insurance approval for breast cancer patients for whom adjuvant proton therapy (PT) is recommended. ...
Read More
Source: PubMed
